Haloperidol versus risperidone for schizophrenia
Información
- DOI:
- https://doi.org/10.1002/14651858.CD012728Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 20 julio 2017see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Esquizofrenia
- Copyright:
-
- Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Sujoy Ray‐ development and writing of protocol
Amita Ray ‐ help with preparation of protocol.
Arun Gopi ‐ help with preparation of protocol.
Robert Hunter ‐ advice, help with preparation of protocol.
Sources of support
Internal sources
-
St. John's Medical College and Hospital, Bangalore, India.
Employs lead author Sujoy Ray.
-
Greater Glasgow Health Board, Glasgow, UK.
Employs review author Robert Hunter.
-
DM Wayanad Institute of Medical Sciences, Wayanad, India.
Employs review authors Amita Ray and Arun Gopi.
External sources
-
No sources of support supplied
Declarations of interest
Sujoy Ray: none known.
Amita Ray: none known.
Arun Gopi: none known.
Robert Hunter: none known.
Acknowledgements
The Cochrane Schizophrenia Group Editorial Base in Nottingham produces and maintains standard text for use in the methods section of their reviews. We have used this text as the basis of what appears here and adapted it as required.
The search terms were developed by the Information Specialist of the Cochrane Schizophrenia Group and the contact author of this protocol.
We would like to thank the staff at Cochrane Schizophrenia for their help and support in developing and editing this protocol and Qijing Bo for providing peer review feedback.
Version history
| Published | Title | Stage | Authors | Version |
| 2017 Jul 20 | Haloperidol versus risperidone for schizophrenia | Protocol | Sujoy Ray, Amita Ray, Arun Gopi, Robert Hunter | |
| Review Title | Stage | Reference | DOI |
| Aripiprazole versus haloperidol for people with schizophrenia and schizophrenia‐like psychoses | Protocol | ||
| Haloperidol versus chlorpromazine for schizophrenia | Full review | ||
| Haloperidol versus placebo for schizophrenia | Full review | ||
| Haloperidol versus risperidone for schizophrenia | ‐ | Current review |
